Disease · MONDO_0010888
Trials21
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 3 more are not shown, since the checks do not confirm them.
1 to 20 of 21
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03749109 | Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis | Phase 2 | 67 | 2022-09-07 | Endometriosis | QUINAGOLIDE | Its record names the disease | ClinicalTrials.gov |
| NCT03778359 | Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis | 5,000 | Endometriosis, Adenomyosis | DIENOGEST, LEUPROLIDE | Its record names the disease | ClinicalTrials.gov | ||
| NCT06913075 | FET in Adenomyosis | Not applicable | 700 | Adenomyosis | GONADORELIN, GONADORELIN ACETATE, LETROZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT07065539 | GnRH Agonist Pretreatment Duration and Letrozole Supplementation in Frozen Embryo Transfer for Adenomyosis Patients | Not applicable | 432 | Adenomyosis of Uterus, Frozen Embryo Transfer (FET) | GONADORELIN, GONADORELIN ACETATE, LETROZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT07162961 | Nintedanib for Improving Reproductive Outcomes in Adenomyosis | Phase 3 | 328 | Adenomyosis of Uterus | NINTEDANIB | Its record names the disease | ClinicalTrials.gov | |
| NCT06581679 | Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer | Not applicable | 184 | Adenomyosis | TRIPTORELIN | Its record names the disease | ClinicalTrials.gov | |
| NCT05151016 | Long-term Use of Mifepristone in the Treatment of Adenomyosis | Early phase 1 | 140 | Adenomyosis, Mifepristone | MIFEPRISTONE | Its record names the disease | ClinicalTrials.gov | |
| NCT03520439 | Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis | Phase 2/3 | 134 | Adenomyosis | MIFEPRISTONE | Its record names the disease | ClinicalTrials.gov | |
| NCT03890042 | Dienogest for Treatment of Adenomyotic Uteri | Not applicable | 100 | Adenomyosis | DIENOGEST, ETHINYL ESTRADIOL | Its record names the disease | ClinicalTrials.gov | |
| NCT05153928 | Management of Uterine Leiomyomata and Adenomyosis | 100 | Abnormal Uterine Bleeding | NORETHINDRONE ACETATE | Its record names the disease | ClinicalTrials.gov | ||
| NCT06719934 | Ttt of Adenomyosis | Phase 1 | 100 | Adenomyosis | DIENOGEST | Its record names the disease | ClinicalTrials.gov | |
| NCT05751876 | Dienogest in Perimenopausal Women With Adenomyosis | 87 | Adenomyosis, Medication Adherence | DIENOGEST | Its record names the disease | ClinicalTrials.gov | ||
| NCT04741295 | Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome | Not applicable | 70 | Adenomyosis, Assisted Reproductive Technology | HEPARIN | Its record names the disease | ClinicalTrials.gov | |
| NCT01601366 | LNG-IUS for Treatment of Dysmenorrhea | Phase 2 | 62 | Adenomyosis | LEVONORGESTREL | Its record names the disease | ClinicalTrials.gov | |
| NCT02556411 | Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) | Not applicable | 50 | Adenomyosis, Chronic Pelvic Pain | LEVONORGESTREL | Its record names the disease | ClinicalTrials.gov | |
| NCT06174792 | Evaluation of the Efficacy and Safety of Drospirenone in the Treatment of Adenomyosis | 40 | Adenomyosis | DROSPIRENONE | Its record names the disease | ClinicalTrials.gov | ||
| NCT01218581 | Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis | Phase 2/3 | 32 | the Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis | GOSERELIN, LETROZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT03037944 | Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri | Early phase 1 | 32 | Adenomyosis | DROSPIRENONE, LEVONORGESTREL | Its record names the disease | ClinicalTrials.gov | |
| NCT02587000 | Adenomyosis and Ulipristal Acetate | Phase 2 | 26 | Adenomyosis | ULIPRISTAL ACETATE | Its record names the disease | ClinicalTrials.gov | |
| NCT01821001 | Vaginal Bromocriptine for Treatment of Adenomyosis | Phase 1 | 1 | Adenomyosis | BROMOCRIPTINE | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0010888/trials